Krystal Biotech Inc (FRA:4KB)
€ 303.6 +6.8 (+2.29%) Market Cap: 9.35 Bil Enterprise Value: 8.63 Bil PE Ratio: 48.12 PB Ratio: 8.30 GF Score: 58/100

Q1 2026 Krystal Biotech Inc Earnings Call Transcript

May 04, 2026 / 12:30PM GMT
Release Date Price: €226 (+3.15%)
Operator

Thank you for standing by, and welcome to the Krystal Biotech first quarter 2026 conference call. (Operator Instructions) As a reminder, today's conference is being recorded.

I would now like to hand the conference over to your host, Stephane Paquette, Vice President of Corporate Development. Please begin.

Stephane Paquette Krystal Biotech Inc;SVP
Corporate Development

Good morning, and thank you all for joining today's call. Earlier today, we released our financial results for the first quarter of 2026. The press release is available on our website at www.krystalbio.com.

We also filed our earnings 8-K and 10-Q with the SEC earlier today. Joining me today will be Krish Krishnan, Chairman and Chief Executive Officer; Suma Krishnan, President of Research and Development; Laurent Goux, Executive Vice President and General Manager for Europe; Christine Wilson, Senior Vice President and Head of US Commercial; and Kate Romano, Chief Accounting Officer.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot